Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.98)
# 2,972
Out of 5,108 analysts
326
Total ratings
54.5%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Reiterated: Sell | $18 | $33.18 | -45.75% | 36 | Nov 6, 2026 | |
| AMWL American Well | Reiterated: Buy | $16 → $18 | $12.11 | +48.64% | 19 | Nov 4, 2026 | |
| PGNY Progyny | Reiterated: Buy | $37 → $38 | $34.37 | +10.56% | 3 | Nov 4, 2026 | |
| TDOC Teladoc Health | Reiterated: Hold | $6 → $8 | $9.41 | -14.98% | 10 | Nov 4, 2026 | |
| WAY Waystar Holding | Rated: Buy | $33 | $28.88 | +14.27% | 5 | Nov 3, 2026 | |
| HNGE Hinge Health | Rated: Buy | $103 → $132 | $115.98 | +13.81% | 7 | Nov 2, 2026 | |
| OMCL Omnicell | Reiterated: Buy | $50 | $38.03 | +31.48% | 57 | Nov 2, 2026 | |
| OMDA Omada Health | Reiterated: Hold | $22 | $18.95 | +16.09% | 7 | Oct 28, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $330 | $310.10 | +6.42% | 48 | Oct 27, 2026 | |
| HQY HealthEquity | Rated: Buy | $125 | $103.46 | +20.82% | 60 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $9 → $10 | $12.71 | -21.32% | 7 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1.75 → $1.5 | $1.50 | - | 27 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $30 | $20.22 | +48.37% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $3.49 | +0.29% | 35 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $21.90 | n/a | 1 | Oct 6, 2015 |
Doximity
Nov 6, 2026
Reiterated: Sell
Price Target: $18
Current: $33.18
Upside: -45.75%
American Well
Nov 4, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $12.11
Upside: +48.64%
Progyny
Nov 4, 2026
Reiterated: Buy
Price Target: $37 → $38
Current: $34.37
Upside: +10.56%
Teladoc Health
Nov 4, 2026
Reiterated: Hold
Price Target: $6 → $8
Current: $9.41
Upside: -14.98%
Waystar Holding
Nov 3, 2026
Rated: Buy
Price Target: $33
Current: $28.88
Upside: +14.27%
Hinge Health
Nov 2, 2026
Rated: Buy
Price Target: $103 → $132
Current: $115.98
Upside: +13.81%
Omnicell
Nov 2, 2026
Reiterated: Buy
Price Target: $50
Current: $38.03
Upside: +31.48%
Omada Health
Oct 28, 2026
Reiterated: Hold
Price Target: $22
Current: $18.95
Upside: +16.09%
Veeva Systems
Oct 27, 2026
Reiterated: Buy
Price Target: $330
Current: $310.10
Upside: +6.42%
HealthEquity
Sep 29, 2026
Rated: Buy
Price Target: $125
Current: $103.46
Upside: +20.82%
Sep 3, 2026
Rated: Hold
Price Target: $9 → $10
Current: $12.71
Upside: -21.32%
Aug 13, 2026
Rated: Hold
Price Target: $1.75 → $1.5
Current: $1.50
Upside: -
Aug 12, 2026
Reiterated: Hold
Price Target: $22 → $30
Current: $20.22
Upside: +48.37%
Jun 2, 2026
Reiterated: Buy
Price Target: $3.5
Current: $3.49
Upside: +0.29%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $21.90
Upside: n/a